The proof for the usage of ketamine in palliative care is limited, and it truly is impossible to suggest any precise treatment regimen. In spite of constrained evidence, a demo of low-dose intravenous or subcutaneous ketamine adjuvant to morphine might be warranted in refractory cancer pain. K